Topical mechlorethamine therapy for early stage mycosis fungoides (Q57610394)

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Clinical course of retrovirus-associated adult T-cell lymphoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

C-Type virus-like particles specifically localized in langerhans cells and related cells of skin and lymph nodes of patients with mycosis fungoides and Sezary’s syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Total skin electron beam irradiation for cutaneous T-cell lymphoma (mycosis fungoides).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Weekly total-skin electron-beam irradiation for mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Prognostic signs and the management of the mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Oral methoxsalen photochemotherapy of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Photochemotherapy for mycosis fungoides: a clinical and histological study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. Long-term follow-up in forty-three patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

PUVA treatment of erythrodermic and plaque type mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Treatment of parapsoriasis and mycosis fungoides: the role of psoralen and long-wave ultraviolet light A (PUVA)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Photochemotherapy for cutaneous T cell lymphoma. A follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Response of mycosis fungoides to topical chemotherapy with mechlorethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Ointment-based mechlorethamine treatment for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Commentary and update: topical chemotherapy with mechlorethamine for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Topical mechlorethamine therapy for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Treatment of advanced stage mycosis fungoides with bleomycin, doxorubicin, and methotrexate with topical nitrogen mustard (BAM-M)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Management of mycosis fungoides--current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Treatment of mycosis fungoides with isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Intralesional interferon in the treatment of early mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Topical carmustine (BCNU) for mycosis fungoides and related disorders: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Combined total body electron beam irradiation and chemotherapy for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Clinical staging for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021

Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2888%2970223-6

7 January 2021